Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease primary myelofibrosis
Phenotype C0023418|leukemia
Sentences 8
PubMedID- 22386731 Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine.
PubMedID- 25148222 Depletion of stat5 blocks tel-syk-induced apmf-type leukemia with myelofibrosis and myelodysplasia in mice.
PubMedID- 22075327 Immunohistochemistry staining (leukocyte phenotyping kit, sun biotech, china) of these cells revealed a total of 55% positivity for cd41 (figure 1c) and 60% positivity for cd42b (figure 1d), while cd13, cd14, cd68, mpo, hla-dr, cd10, cd19, cd3, cd5, and cd7 were all negative a bone marrow biopsy indicated acute leukemia with myelofibrosis (figure 1e &1f).
PubMedID- 25126488 Rare aggressive natural killer cell leukemia presented with bone marrow fibrosis - a diagnostic challenge.
PubMedID- 23628022 [pathological characteristics of leukemia patients with secondary myelofibrosis and their relationship with the prognosis of disease].
PubMedID- 24201159 Transformed acute myeloid leukemia in myelofibrosis results in a median survival of less than 5 months.
PubMedID- 22379292 Coexistence of chronic lymphocytic leukemia (cll) with myelofibrosis is a rare association with only isolated case reports in the literature.
PubMedID- 24307514 Thalidomide treatment in a myelofibrosis patient with leukemia transformation.

Page: 1